Table 1.
Disturbed miRNAs reported in human AD studies and their relation to Aβ pathways.
miRNA | Sample | Regulation | Relevant pathway | References |
---|---|---|---|---|
miR-15a miR-15 b |
Serum | Downregulation | Downregulates BACE1 expression |
Satoh et al., 2015; Lang et al., 2016; Li and Wang, 2018 |
miR-29a | Brain CSF Serum |
Down Up Down |
BACE1 | Hébert et al., 2008; Geekiyanage et al., 2012; Müller et al., 2016 |
miR-29b | Blood | Down | BACE1 | Satoh et al., 2015 |
miR-29c | Brain | Down | BACE1 | Lei et al., 2015 |
miR-20b | Brain | Down | APP | Nunez-Iglesias et al., 2010 |
miR-21-5p | Brain | Up | APP | Giuliani et al., 2021 |
miR-16 | CSF | Down | APP | Müller et al., 2014 |
miR-9 | Brain | Down | APP | Hébert et al., 2008 |
miR-30c | Brain | Down | APP | Cogswell et al., 2008 |
miR-101a-3p | Brain | Down | APP | Hébert et al., 2008 |
miR-188 | Brain, Serum | Down | APP | Kou et al., 2020 |
miR-106a | Brain Serum |
Down Up |
APP | Wang et al., 2011; Cheng et al., 2015 |
miR-106b | Brain Whole blood |
Down Up |
APP | Hébert et al., 2008; Cheng et al., 2015 |
miR-138-5p | Plasma Exosomes | Up | APP | Lugli et al., 2015 |
miR-138 | Brain, CSF | Variant | APP | Boscher et al., 2019 |
miR-135b | Blood | Down | BACE1 | Zhang et al., 2016 |
miR-124 | CSF | Down | APP | Burgos et al., 2014 |
miR-155 | Peripheral Blood mononuclear cells | Upregulated | Inhibits Aβ catabolism | Guedes et al., 2016 |
miR-34 | Peripheral Blood mononuclear cells | Upregulated | Aβ clearance | Basavaraju and de Lencastre, 2016 |
miR-181b | Peripheral Blood mononuclear cells | Upregulated | Aβ clearance | Kumar and Reddy, 2016 |
miR-181c | Serum | Downregulated | APP | Geekiyanage et al., 2012 |
miR-186 | Brain | Downregulated | BACE1 | Ben Halima et al., 2016 |
miR-346 | Human Neuron Enriched culture | Upregulated | APP | Long et al., 2019 |
miR-338 | Hippocampus | Downregulated | APP | Qian et al., 2019 |
miR-200 | Brain | Upregulated | SIRT1, Aβ accumulation, Apoptosis | Zhang et al., 2017 |